Policy statement - Recommendations for the prevention of perinatal group B streptococcal (GBS) disease

Pediatrics

Volumn 128, Issue 3, 2011, Pages 611-616

  Brady, Michael T ^a   Bernstein, Henry H ^a   Byington, Carrie L ^a   Edwards, Kathryn M ^a   Fisher, Margaret C ^a   Glode, Mary P ^a   Jackson, Mary Anne ^a   Keyserling, Harry L ^a   Kimberlin, David W ^a   Maldonado, Yvonne A ^a   Orenstein, Walter A ^a   Schutze, Gordon E ^a   Willoughby, Rodney E ^a   Papile, Lu Ann ^a   Cummings, James ^a   Baley, Jill E ^a   Bhutani, Vinod K ^a   Carlo, Waldemar A ^a   Kumar, Praveen ^a   Polin, Richard A ^a   Tan, Rosemarie C ^a   Wang, Kasper S ^a   Watterberg, Kristi L ^a   more..

^a NONE

Author keywords

Diagnosis; Early onset; Group B Streptococcus; Penicillin allergy; Prophylaxis; Treatment

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CLINDAMYCIN; PENICILLIN G; VANCOMYCIN;

ALGORITHM; ANTIBIOTIC PROPHYLAXIS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; COMPARATIVE STUDY; DRUG INDICATION; GROUP B STREPTOCOCCAL INFECTION; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION PREVENTION; INTRAPARTUM CARE; LABORATORY TEST; MEDICAL SOCIETY; NEWBORN; NEWBORN CARE; NEWBORN SEPSIS; PENICILLIN ALLERGY; PERINATAL INFECTION; PRACTICE GUIDELINE; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PUBLICATION; RECOMMENDED DRUG DOSE; REVIEW; SCREENING TEST; UNITED STATES;

ALGORITHMS; ANTIBIOTIC PROPHYLAXIS; CEFAZOLIN; CESAREAN SECTION; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT, NEWBORN; MALE; OBSTETRIC LABOR, PREMATURE; PENICILLINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 80052357643     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1466     Document Type: Review

References (28)

1. Baker C.J. Early onset group B streptococcal disease. J Pediatr. 1978;93(1):124-125 (Pubitemid 8354006)
2. Baker C.J., Barrett F.F., Gordon R.C., Yow M.D. Suppurative meningitis due to streptococci of Lancefield group B: A study of 33 infants. J Pediatr. 1973;82(4):724-729
3. Baker C.J., Barrett F.F. Transmission of group B streptococci among parturient women and their neonates. J Pediatr. 1973;83(6):919-925
4. Boyer K.M., Gotoff S.P. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother. 1985;35:267-280
5. Schrag S., Gorwitz R., Fultz-Butts K., Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1-22
6. Van Dyke M.K., Phares C.R., Lynfield R., et al. Evaluation of universal antenatal screening for group B Streptococcus. N Engl J Med. 2009;360(25):2626-2636
7. Pulver L.S., Hopfenbeck M.M., Young P.C., et al. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis. J Perinatol. 2009;29(1):20-25
8. Phares C.R., Lynfield R., Farley M.M., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299(17):2056-2065 (Pubitemid 351656587)
9. Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations: United States, 2003-2005. MMWR Morb Mortal Wkly Rep. 2007;56(28):701-705
10. Pinto N.M., Soskolne E.I., Pearlman M.D., Faix R.G. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: Residual problems. J Perinatol. 2003;23(4):265-271 (Pubitemid 36764113)
11. Puopolo K.M., Madoff L.C., Eichenwald E.C. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115(5):1240-1246 (Pubitemid 43843226)
12. Garland S.M., Fliegner J.R. Group B. Streptococcus (GBS) and neonatal infections: The case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol. 1991;31(2):119-122
13. Boyer K.M., Gotoff S.P. Prevention of earlyonset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314(26):1665-1669 (Pubitemid 16097843)
14. Fiore Mitchell T., Pearlman M.D., Chapman R.L., Bhatt-Mehta V., Faix R.G. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol. 2001;98(6):1075-1079 (Pubitemid 34075333)
15. Allegaert K., Van Mieghem T., Verbesselt R., et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol. 2009;200(2):170.e1-170.e7
16. Popović J., Grujić Z., Sabo A. Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women. J Clin Pharm Ther. 2007;32(6):595-602 (Pubitemid 350135112)
17. Blaschke A.J., Pulver L.S., Korgenski E.K., Savitz L.A., Daly J.A., Byington C.L. Clindamycinresistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease. J Pediatr. 2010;156(3):501-503
18. Ansong A.K., Smith P.B., Benjamin D.K., et al. Group B streptococcal meningitis: Cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Dev. 2009;85(10 suppl):S5-S7
19. Garges H.P., Moody M.A., Cotten C.M., et al. Neonatal meningitis: What is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics. 2006;117(4):1094-1100 (Pubitemid 46071500)
20. Stoll B.J., Hansen N., Fanaroff A.A., et al. To tap or not to tap: High likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics. 2004;113(5):1181-1186 (Pubitemid 38580678)
21. Wiswell T.E., Baumgart S., Gannon C.M., Spitzer A.R. No lumbar puncture in the evaluation for early neonatal sepsis: Will meningitis be missed? Pediatrics. 1995;95(6):803-806
22. Ramus R., McIntire D., Wendall G. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section at term [abstract]. Am J Obstet Gynecol. 1999;180(suppl):S85
23. Håkansson S., Axemo P., Bremme K., et al; Swedish Working Group for the Prevention of Perinatal Group B Streptococcal Infections. Group B streptococcal carriage in Sweden: A national study on risk factors for mother and infant colonisation. Acta Obstet Gynecol Scand. 2008;87(1):50-58
24. Greenberg D.N., Yoder B.A. Changes in the differential white blood cell count in screening for group B streptococcal sepsis. Pediatr Infect Dis J. 1990;9(12):886-889
25. Hsu K.K., Pelton S.I., Shapiro D.S. Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis. 2003;45(1):23-27 (Pubitemid 36165026)
26. Gerdes J.S., Polin R.A. Sepsis screen in neonates with evaluation of plasma fibronectin. Pediatr Infect Dis J. 1987;6(5):443-446 (Pubitemid 17072085)
27. Ottolini M.C., Lundgren K., Mirkinson L.J., Cason S., Ottolini M.G. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J. 2003;22(5):430-434 (Pubitemid 36578745)
28. Escobar G.J., Li D.K., Armstrong M.A., et al. Neonatal sepsis workups in infants ≥2000 grams at birth: A population-based study. Pediatrics. 2000;106(2 pt 1):256-263 (Pubitemid 30636392)